European marketing authorization for Mounjaro

被引：0

|

作者：

Coquard-Schmidt, Barbara

机构：

来源：

CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2024年 / 28卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：83 / 83

页数：1

相关论文

共 50 条

[1] European marketing authorization for Mounjaro® (tirzepatide) for weight control in obese or overweight adults with at least one comorbidity
不详
[J]. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2023, 27 (06): : 191 - 191
[2] Bydureon, granted marketing authorization by the European Commission
Idris, Iskandar
[J]. DIABETES OBESITY & METABOLISM, 2011, 13 (09): : 866 - 866
[3] EUROPEAN CONDITIONAL MARKETING AUTHORIZATION - DOES EARLY MARKETING AUTHORIZATION TRANSLATE INTO EARLY REIMBURSEMENT AND PATIENT ACCESS?
Macaulay, R.
Rothwell, S.
Sutcliffe, D.
[J]. VALUE IN HEALTH, 2018, 21 : S160 - S160
[4] Main deficiencies concerning the European Marketing Authorization: Part II
Legras, Y
[J]. DRUG INFORMATION JOURNAL, 2001, 35 (02): : 357 - 367
[5] Obtaining marketing authorization for nucleic acid vaccines in the European union
Cichutek, K
[J]. DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 : 178 - 185
[6] European Medicines Agency grants full marketing authorization for pazopanib
Chamberlain, Dominic
[J]. FUTURE ONCOLOGY, 2013, 9 (09) : 1264 - 1264
[7] Main Deficiencies Concerning the European Marketing Authorization: Part II
Yvonne Legras
[J]. Drug information journal : DIJ / Drug Information Association, 2001, 35 (2): : 357 - 367
[8] Onglyza get a European marketing authorization in the treatment of type 2 diabetes
不详
[J]. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2010, 14 (1-2): : 42 - 42
[9] Saphnelo® Obtaining a European Marketing Authorization in the treatment of systemic lupus erythematosus
不详
[J]. ACTUALITES PHARMACEUTIQUES, 2022, 61 (616): : 9 - 9
[10] First conditional marketing authorization approval in the European Union for hemophilia "A" gene therapy
VandenDriessche, Thierry
Pipe, Steven W.
Pierce, Glenn F.
Kaczmarek, Radoslaw
[J]. MOLECULAR THERAPY, 2022, 30 (11) : 3335 - 3336

← 1 2 3 4 5 →